Elisa Alonso

Summary

Country: Mexico

Publications

  1. doi request reprint Genetics of Alzheimer's disease
    María Elisa Alonso Vilatela
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico
    Arch Med Res 43:622-31. 2012
  2. doi request reprint Clinical and genetic characteristics of Mexican Huntington's disease patients
    Maria Elisa Alonso
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Insurgentes Sur 3877, Col La Fama, Tlalpan, 14269 Mexico, D F, Mexico
    Mov Disord 24:2012-5. 2009
  3. doi request reprint Presymptomatic diagnosis in Huntington's disease: the Mexican experience
    Maria Elisa Alonso
    Neurogenetics and Molecular Biology Department, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez INNN MVS, Mexico City, Mexico
    Genet Test Mol Biomarkers 13:717-20. 2009
  4. pmc Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease
    Astrid Rasmussen
    Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    BMC Med Genet 11:4. 2010
  5. ncbi request reprint Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population
    Elisa Alonso
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico
    Mov Disord 22:1050-3. 2007
  6. ncbi request reprint Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma
    Astrid Rasmussen
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico
    J Neurosurg 104:389-94. 2006
  7. ncbi request reprint Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection
    Antonio Arauz
    Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico
    Cerebrovasc Dis 24:210-4. 2007

Collaborators

  • Ana Luisa Sosa
  • Carlos Cantu
  • Antonio Arauz
  • Marisol Lopez
  • Astrid Rasmussen
  • Maria Elisa Alonso
  • Petra Yescas
  • Marisol López-López
  • Adriana Ochoa
  • María Elisa Alonso Vilatela
  • Itziar Familiar
  • Mireya Chavez
  • Yaneth Rodriguez
  • Rosario Macias
  • Petra Yescas-Gomez
  • Sanjay I Bidichandani
  • Irene De Biase
  • Marie Catherine Boll
  • Catherine Boll
  • Rogelio Revuelta
  • Iván Ortiz
  • Samuel Canizales-Quinteros
  • Sonia Nava-Salazar
  • María Teresa Tusié-Luna

Detail Information

Publications7

  1. doi request reprint Genetics of Alzheimer's disease
    María Elisa Alonso Vilatela
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico
    Arch Med Res 43:622-31. 2012
    ..In the end, the knowledge of the pathophysiological mechanisms leading to AD will enable the development of more accurate diagnostic tests and new disease-treating strategies...
  2. doi request reprint Clinical and genetic characteristics of Mexican Huntington's disease patients
    Maria Elisa Alonso
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Insurgentes Sur 3877, Col La Fama, Tlalpan, 14269 Mexico, D F, Mexico
    Mov Disord 24:2012-5. 2009
    ..04 +/- 3.02) in normal alleles and the presence of new mutations suggest that the overall prevalence of HD in the Mexican population could be expected to be within range of, or higher than, that reported for Europeans...
  3. doi request reprint Presymptomatic diagnosis in Huntington's disease: the Mexican experience
    Maria Elisa Alonso
    Neurogenetics and Molecular Biology Department, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez INNN MVS, Mexico City, Mexico
    Genet Test Mol Biomarkers 13:717-20. 2009
    ..Even if this is a small sample, it is the first report of PT in a Latin-American population in which we have been faced with the same problems referred to in larger series...
  4. pmc Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease
    Astrid Rasmussen
    Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    BMC Med Genet 11:4. 2010
    ..Disease management is centered on tumor surveillance that allows early detection and treatment. Presymptomatic genetic testing is therefore recommended, including in at-risk children...
  5. ncbi request reprint Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population
    Elisa Alonso
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico
    Mov Disord 22:1050-3. 2007
    ..6%). In the SCA2 patients we identified 6 individuals with the rare (CAG)(33) allele, 2 of whom showed early onset ataxia. The distribution of dominant ataxia mutations in Mexicans is distinct from other populations...
  6. ncbi request reprint Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma
    Astrid Rasmussen
    Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico
    J Neurosurg 104:389-94. 2006
    ..The authors studied a series of patients with CNS hemangioblastomas and their families to identify germline mutations in the VHL tumor suppressor gene and to establish a predictive testing and screening protocol...
  7. ncbi request reprint Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection
    Antonio Arauz
    Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico
    Cerebrovasc Dis 24:210-4. 2007
    ..We examined the potential association between Hcy, folate, vitamin B(12) levels and 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms in patients with cerebral infarct caused by sCAD...